Marex Group’s Chemours CC Stock Holding History

Marex Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$270K	Sell	12,261 -7,270	-37%	-$127K	﹤0.01%	810
2025 Q4	$230K	Buy	+19,531	New	+$251K	﹤0.01%	799
2024 Q2	–	Sell	-9,500	Closed	-$249K	–	641
2024 Q1	$249K	Buy	+9,500	New	+$271K	0.01%	353

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marex Group's CC Position: Q1 2026 in Review

Marex Group reduced its Chemours (CC) stake by 37% in Q1 2026, selling an estimated $127K and leaving 12,261 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Marex Group first reported a position in CC in Q1 2024 and has held it in 3 quarters since. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Marex Group held 12,261 shares of Chemours worth $270K as of Q1 2026.
Marex Group sold 7,270 Chemours shares in Q1 2026, an estimated $127K.
Chemours made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #810 holding.
Marex Group first reported a position in Chemours in Q1 2024 and has held it in 3 quarters since.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.